TOURMALINE BIO INC. - COMMON STOCK

18.07

21-January-25 11:41:29

15 minutes delayed

Stocks

+0.07

+0.36%

Today's range

17.91 - 18.85

ISIN

N/A

Source

NASDAQ

Tourmaline Bio Announces Proposed Public Offering of Common Stock

24 Jan 2024 15:05:48 By Nasdaq GlobeNewswire
Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)

08 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
Tourmaline Bio added to the NASDAQ Biotechnology Index

15 Dec 2023 15:00:00 By Nasdaq GlobeNewswire
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board

14 Dec 2023 06:30:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.